Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00328718Phase 3Completed
A Phase 3 trial of salmeterol, fluticasone propionate nasal spray in asthma, sponsored by GSK. Started Oct 2005; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00328718.